chr19:35154730:> Detail (hg38)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr19:35,645,633-35,660,784 |
| hg38 | chr19:35,154,730-35,169,881 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| 0.003 | squamous cell carcinoma | NA | LHGDN | Detail | |
| <0.001 | Constitutional Symptom | NA | BeFree | Detail | |
| 0.003 | cystic fibrosis | NA | BeFree,LHGDN | Detail | |
| <0.001 | Cytomegalovirus Infections | NA | BeFree | Detail | |
| 0.003 | Dehydration | NA | BeFree,LHGDN | Detail | |
| <0.001 | Graft-vs-Host Disease | NA | BeFree | Detail | |
| <0.001 | Leukemia, Myelocytic, Acute | NA | BeFree | Detail | |
| 0.003 | melanoma | NA | LHGDN | Detail | |
| <0.001 | myelofibrosis | NA | BeFree | Detail | |
| 0.007 | Neoplasm Metastasis | NA | BeFree,LHGDN | Detail | |
| 0.003 | Pancreatic Neoplasm | NA | LHGDN | Detail | |
| <0.001 | seminoma | NA | BeFree | Detail | |
| 0.003 | Stomach Neoplasms | NA | LHGDN | Detail | |
| <0.001 | synovial sarcoma | NA | BeFree | Detail | |
| <0.001 | Testicular Neoplasms | NA | BeFree | Detail | |
| <0.001 | Tumor Progression | NA | BeFree | Detail | |
| <0.001 | Sarcoma, Epithelioid | NA | BeFree | Detail | |
| <0.001 | embryonal carcinoma | NA | BeFree | Detail | |
| <0.001 | Rhabdoid Tumor | NA | BeFree | Detail | |
| <0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
| <0.001 | Liver and Intrahepatic Biliary Tract Carcinoma | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of liver | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
| <0.001 | Hematologic Neoplasms | We evaluated 688 patients with hematologic malignancies (48% myeloid and 52% lym... | BeFree | 24907627 | Detail |
| <0.001 | Carcinogenesis | NA | BeFree | Detail | |
| <0.001 | myelofibrosis | In conclusion, a simple model which includes: age, JAK2 V617F-status and constit... | BeFree | 22280409 | Detail |
| <0.001 | breast carcinoma | NA | BeFree | Detail | |
| <0.001 | Constitutional Symptom | In conclusion, a simple model which includes: age, JAK2 V617F-status and constit... | BeFree | 22280409 | Detail |
| <0.001 | Primary myelofibrosis | In conclusion, a simple model which includes: age, JAK2 V617F-status and constit... | BeFree | 22280409 | Detail |
| <0.001 | Morphologically altered structure | NA | BeFree | Detail | |
| <0.001 | Distal-Type Epithelioid Sarcoma | NA | BeFree | Detail | |
| <0.001 | Proximal-Type Epithelioid Sarcoma | NA | BeFree | Detail | |
| 0.003 | Mammary Neoplasms | NA | LHGDN | Detail | |
| <0.001 | Non-Neoplastic Disorder | NA | BeFree | Detail | |
| <0.001 | liver carcinoma | NA | BeFree | Detail | |
| <0.001 | Primary myelofibrosis | NA | BeFree | Detail | |
| 0.002 | Behcet Syndrome | NA | GAD | Detail | |
| <0.001 | Malignant neoplasm of breast | NA | BeFree | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We evaluated 688 patients with hematologic malignancies (48% myeloid and 52% lymphoid) and a median ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In conclusion, a simple model which includes: age, JAK2 V617F-status and constitutional symptoms can... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In conclusion, a simple model which includes: age, JAK2 V617F-status and constitutional symptoms can... | DisGeNET | Detail |
| In conclusion, a simple model which includes: age, JAK2 V617F-status and constitutional symptoms can... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs386626619 dbSNP
- Genome
- hg38
- Position
- chr19:35,154,730-35,169,881
- Variant Type
- snv
Genome browser